Literature DB >> 10800301

Using non-nucleoside reverse transcriptase inhibitors in treating HIV disease: where are the therapeutic niches?

V Idemyor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10800301      PMCID： PMC2640545     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  4 in total

Review 1.  Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

Authors:  C C Carpenter; M A Fischl; S M Hammer; M S Hirsch; D M Jacobsen; D A Katzenstein; J S Montaner; D D Richman; M S Sáag; R T Schooley; M A Thompson; S Vella; P G Yeni; P A Volberding
Journal:  JAMA       Date:  1996-07-10       Impact factor: 56.272

2.  Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel.

Authors:  C C Carpenter; M A Fischl; S M Hammer; M S Hirsch; D M Jacobsen; D A Katzenstein; J S Montaner; D D Richman; M S Saag; R T Schooley; M A Thompson; S Vella; P G Yeni; P A Volberding
Journal:  JAMA       Date:  1997-06-25       Impact factor: 56.272

3.  A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

Authors:  J S Montaner; P Reiss; D Cooper; S Vella; M Harris; B Conway; M A Wainberg; D Smith; P Robinson; D Hall; M Myers; J M Lange
Journal:  JAMA       Date:  1998-03-25       Impact factor: 56.272

4.  Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.

Authors:  S Staszewski; J Morales-Ramirez; K T Tashima; A Rachlis; D Skiest; J Stanford; R Stryker; P Johnson; D F Labriola; D Farina; D J Manion; N M Ruiz
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245
  4 in total
  1 in total

1.  Albumin nanoparticles coated with polysorbate 80 as a novel drug carrier for the delivery of antiretroviral drug-Efavirenz.

Authors:  Josephine Leno Jenita; Vijaya Chocalingam; Barnabas Wilson
Journal:  Int J Pharm Investig       Date:  2014-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.